DocDollars

Genentech, Inc.

CA · United States · Reporting entity ID 100000000089

Total reported 2019–2025
$3.21B
#5 of 2,960 reporting companies — 3.9% of all reported industry payments
$950.8M in general payments across 20,525 records, plus $2.26B in research funding across 165,689 records.

How it breaks down

General payments $950,826,236
Research funding $2,256,966,251

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Genentech, Inc. reported $3.21B to US doctors and teaching hospitals from 2019 to 2025, ranking #5 of 2,960 reporting companies. 70% of that was research funding and 30% general payments such as consulting, speaking, food and travel. 20,525 general payment records and 165,689 research records were filed.

Common questions about Genentech, Inc.

How much has Genentech, Inc. paid US doctors?

Genentech, Inc. reported $3,207,792,488 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $950,826,236 in general payments, $2,256,966,251 in research funding.

How does Genentech, Inc. rank among drug and device companies?

It ranks #5 of 2,960 reporting entities by total reported value, about 3.9% of all industry payments in the dataset.

Does a payment from Genentech, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.